BioCentury
ARTICLE | Company News

Inverness, Matritech deal

September 3, 2007 7:00 AM UTC

IMA will acquire substantially all of MZT's assets for $36 million in stock, which is the equivalent of $0.58 for each of MZT's 62 million outstanding shares. The price is a 190% premium to MZT's clos...